Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesIs Cystatin C a Promising Parameter to Determine Postnatal Outcome of Prenatally Diagnosed Infravesical Obstruction
The Journal of Urology, 10/01/09
Acar O et al. – In fetuses with prenatal ultrasound signs consistent with infravesical obstruction urinary levels of cystatin C progressively increase in consecutive samples. Amniotic fluid may represent fetal urine sample in suspected prenatal infravesical obstruction in terms of cystatin C level. Amniotic fluid cystatin C level was significantly increased in obstructed fetuses compared to normal controls. Cystatin C level in amniotic fluid sample may be sufficient to provide prognostic information in prenatally diagnosed infravesical obstruction.
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09
Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09
Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: Results in 1005 patients
Annals of Oncology, 11/10/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence
Journal of Clinical Oncology, 11/02/09
Sonographic detection of renal and ureteral stones. Value of the twinkling sign
International Braz J Urol, 10/30/09
Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09
TVT and TVT-O for surgical treatment of primary stress urinary incontinence: prospective randomized trial
International Urogynecology Journal, 11/17/09
Fesoterodine for the treatment of urinary incontinence and overactive bladder
Therapeutics and Clinical Risk Management, 11/04/09
Article Search
Sponsor